These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 19617010

  • 1. [Carboxypeptidase-G2 administration after high-dose methotrexate. Treatment and drug interactions].
    Cózar Olmo JA, Martínez Colmenero C, Peláez Pleguezuelos I, Leiva Gea I, López García AB, de la Cruz Moreno J.
    An Pediatr (Barc); 2009 Sep; 71(3):230-4. PubMed ID: 19617010
    [Abstract] [Full Text] [Related]

  • 2. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC.
    Cancer; 2004 May 15; 100(10):2222-32. PubMed ID: 15139068
    [Abstract] [Full Text] [Related]

  • 3. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
    Schwartz S, Borner K, Müller K, Martus P, Fischer L, Korfel A, Auton T, Thiel E.
    Oncologist; 2007 Nov 15; 12(11):1299-308. PubMed ID: 18055849
    [Abstract] [Full Text] [Related]

  • 4. Glucarpidase for the treatment of life-threatening methotrexate overdose.
    Tuffaha HW, Al Omar S.
    Drugs Today (Barc); 2012 Nov 15; 48(11):705-11. PubMed ID: 23170306
    [Abstract] [Full Text] [Related]

  • 5. Understanding and managing methotrexate nephrotoxicity.
    Widemann BC, Adamson PC.
    Oncologist; 2006 Jun 15; 11(6):694-703. PubMed ID: 16794248
    [Abstract] [Full Text] [Related]

  • 6. Effective removal of methotrexate by high-flux hemodialysis.
    Saland JM, Leavey PJ, Bash RO, Hansch E, Arbus GS, Quigley R.
    Pediatr Nephrol; 2002 Oct 15; 17(10):825-9. PubMed ID: 12376811
    [Abstract] [Full Text] [Related]

  • 7. Glucarpidase following high-dose methotrexate: update on development.
    Patterson DM, Lee SM.
    Expert Opin Biol Ther; 2010 Jan 15; 10(1):105-11. PubMed ID: 19925307
    [Abstract] [Full Text] [Related]

  • 8. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
    Widemann BC, Balis FM, Shalabi A, Boron M, O'Brien M, Cole DE, Jayaprakash N, Ivy P, Castle V, Muraszko K, Moertel CL, Trueworthy R, Hermann RC, Moussa A, Hinton S, Reaman G, Poplack D, Adamson PC.
    J Natl Cancer Inst; 2004 Oct 20; 96(20):1557-9. PubMed ID: 15494606
    [Abstract] [Full Text] [Related]

  • 9. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
    Svahn T, Mellgren K, Harila-Saari A, Åsberg A, Kanerva J, Jónsson Ó, Vaitkeviciene G, Stamm Mikkelssen T, Schmiegelow K, Heldrup J.
    Pediatr Blood Cancer; 2017 Jul 20; 64(7):. PubMed ID: 27966809
    [Abstract] [Full Text] [Related]

  • 10. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
    Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC.
    Cancer; 1995 Aug 01; 76(3):521-6. PubMed ID: 8625136
    [Abstract] [Full Text] [Related]

  • 11. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
    Nowicki TS, Bjornard K, Kudlowitz D, Sandoval C, Jayabose S.
    J Pediatr Hematol Oncol; 2008 Dec 01; 30(12):950-2. PubMed ID: 19131789
    [Abstract] [Full Text] [Related]

  • 12. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
    Tuffaha HW, Al Omar S.
    J Oncol Pharm Pract; 2011 Jun 01; 17(2):136-40. PubMed ID: 19833686
    [Abstract] [Full Text] [Related]

  • 13. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
    Hempel L, Misselwitz J, Fleck C, Kentouche K, Leder C, Appenroth D, Rost M, Zintl F.
    Med Pediatr Oncol; 2003 Jun 01; 40(6):348-54. PubMed ID: 12692801
    [Abstract] [Full Text] [Related]

  • 14. [The need for a better definition of therapeutic indications of carboxypeptidase in delayed elimination of methotrexate].
    Blasco H, Silly S, Tournamille JF, Gyan E, Sénécal D, André V, Colombat P, Le Guellec C.
    Therapie; 2008 Jun 01; 63(1):19-28. PubMed ID: 18387272
    [Abstract] [Full Text] [Related]

  • 15. Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use.
    Snyder RL.
    Am J Health Syst Pharm; 2007 Jun 01; 64(11):1163-9. PubMed ID: 17519458
    [Abstract] [Full Text] [Related]

  • 16. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
    Kobayashi H, Morita T, Hirata Y, Kato T, Okada Y, Sato T.
    Gan To Kagaku Ryoho; 2000 Mar 01; 27(3):475-8. PubMed ID: 10740644
    [Abstract] [Full Text] [Related]

  • 17. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
    Cecyn KZ, Lee J, Oguro T, Petrilli AS, Bordin JO.
    Am J Hematol; 2003 Mar 01; 72(3):209-11. PubMed ID: 12605394
    [Abstract] [Full Text] [Related]

  • 18. Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.
    McBride A, Antonia SJ, Haura EB, Goetz D.
    J Pharm Pract; 2012 Aug 01; 25(4):477-85. PubMed ID: 22550162
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate nephrotoxicity: Novel treatment, new approach.
    Iqbal S, Armaghani A, Aiyer R, Kazory A.
    J Oncol Pharm Pract; 2013 Dec 01; 19(4):373-6. PubMed ID: 24255083
    [Abstract] [Full Text] [Related]

  • 20. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
    Turello R, Rentsch K, Di Paolo E, Popovic MB.
    Pediatr Blood Cancer; 2008 Jan 01; 50(1):154-6. PubMed ID: 17387702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.